Drug application
DEXTROMETHORPHAN POLISTIREX (DEXTROMETHORPHAN POLISTIREX)
Drugs@FDA ANDA 218417 · AUROBINDO PHARMA LTD
Key facts
| Drug name | DEXTROMETHORPHAN POLISTIREX |
|---|---|
| Active ingredients | DEXTROMETHORPHAN POLISTIREX |
| Application type | ANDA |
| Application number | 218417 |
| Company | AUROBINDO PHARMA LTD |
| Dosage forms | SUSPENSION, EXTENDED RELEASE, ORAL |
| Strength | EQ 30MG HYDROBROMIDE/5ML |
| Marketing status | Over-the-counter |
| Reference listed drug | No |
| Latest submission status date | Apr 15, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.